Sacituzumab tirumotecan improves OS in mTNBC
- PMID: 40269173
- DOI: 10.1038/s41571-025-01022-0
Sacituzumab tirumotecan improves OS in mTNBC
References
Original article
-
- Yin, Y. et al. Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial. Nat. Med. https://doi.org/10.1038/s41591-025-03630-w (2025) - DOI - PubMed
LinkOut - more resources
Full Text Sources